Original articleMean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis
Introduction
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are the most widely used assays for measuring acute phase response due to their reliability, reproducibility and cost effectiveness [1], [2], [3], [4]. On the other hand, ESR is influenced by several factors unrelated to inflammation such as age, sex, anemia and renal failure [2], [3], [4]. Rapid serum level changes reflecting the rate of inflammation are one of the major advantages of CRP compared to ESR although it shares some of the disadvantages of ESR [2], [4], [5].
ESR and CRP correlate closely with clinical disease activity in patients with rheumatoid arthritis (RA) and to a lesser extent with ankylosing spondylitis (AS) [3], [4], [5], [6], [7]. However, certain studies revealed a discordance between ESR or CRP levels and the disease activity in RA [2], [5], [8], [9].
Mean platelet volume (MPV) is a parameter generated by full blood count analyzers as part of the routine complete blood count (CBC) test cycle which is usually overlooked by clinicians [10]. MPV correlates with the platelet function and activation [11], [12], [13], [14]. MPV is influenced inversely by inflammation as shown in ulcerative colitis and Crohn's disease [14]. An association between RA activity and MPV has been demonstrated in two studies previously [15], [16]. However, its correlation with disease activity indices was not investigated.
The present study aimed to investigate the correlation of MPV and clinical activity indices, namely Bath ankylosing spondylitis disease activity index (BASDAI) and Disease activity score (DAS28), in AS and RA, respectively.
Section snippets
Patients and controls
Thirty-two RA patients and 30 AS patients were enrolled retrospectively into the study. Age-matched 26 osteoarthritis (OA) patients and 29 healthy subjects were used as control groups for RA and AS patients, respectively. All RA patients fulfilled the 1987 ACR criteria for RA [17] and AS patients fulfilled the modified New York criteria [18]. Disease activity was determined by DAS28 score [19] in RA patients and by BASDAI score [20] in AS patients. All patients had active disease (DAS28 score
Results
Demographic features, clinical activity scores and laboratory findings of RA and AS patients and control groups are given in Table 1. As expected acute phase reactant (APR) levels were significantly higher in active RA and AS patients (Table 1). After treatment, levels of these markers decreased significantly (Table 2). BASDAI scores in AS patients (6.3 ± 1.6 vs 2.1 ± 1.0; p = <0.001) and DAS28 scores in RA patients (5.7 ± 0.8 vs 3.4 ± 1.3; p = <0.001) decreased significantly after two months.
Initial
Discussion
Our study revealed that MPV decreased in active RA and AS patients as compared to controls. Furthermore, MPV increased after treatment of RA and AS. A negative correlation between MPV and BASDAI scores was observed in AS patients after two months of treatment modification. Our data did not disclose a correlation between MPV values and the disease activity index assessed by DAS28 in RA patients.
Although ESR and CRP mirror disease activity in RA and AS [3], [4], [5], [6], [7] they may present
References (26)
The role of the laboratory in the evaluation of rheumatic diseases
Clin Cornerstone
(1999)- et al.
Mean platelet volume: a useful marker of inflammatory bowel disease activity
Am J Gastroenterol
(2001) - et al.
Relationships between platelets and inflammatory markers in rheumatoid arthritis
Clin Chim Acta
(2004) - et al.
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Blood
(2001) - et al.
Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men
Thromb Res
(2006) Markers of disease in rheumatoid arthritis
Curr Opin Rheumatol
(2000 May)- et al.
Laboratory testing in the rheumatic diseases: a practical review
South Med J
(2005) Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis
J Clin Lab Anal
(2000)Diagnostic tests for rheumatic disease: clinical utility revisited
South Med J
(2005)- et al.
Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis
Ann Clin Lab Sci
(2004)
Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review
J Rheumatol
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
Arthritis Res Ther
Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
J Rheumatol
Cited by (313)
Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis
2023, International ImmunopharmacologyCan the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
2023, Radiotherapy and OncologyIncreased serum IL-41 is associated with disease activity in rheumatoid arthritis
2023, Clinica Chimica ActaHematologic parameters and disease activity in patients with primary Sjögren's syndrome
2022, Egyptian RheumatologistNeutrophil/lymphocyte ratio but not platelet/lymphocyte ratio and mean platelet volume can be an indicator of subclinical inflammation in patients with Familial Mediterranean Fever
2022, Egyptian RheumatologistCitation Excerpt :The platelet count, mean platelet volume (MPV) and platelet distribution width (PDW) are the most important indices of platelet function and activation [1,15]. MPV, a component of routine complete blood count (CBC) tests, is inversely affected by systemic inflammation [1,16]. MPV levels were shown to be lower in active inflammatory bowel diseases, rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and increased MPV values were reported after treatment [16,17].
The relation of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and mean platelet volume with idiopathic acute anterior uveitis
2024, European Journal of Inflammation